• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

豚鼠窦房结中β-肾上腺素能受体的调节

Regulation of beta-adrenoceptors in the guinea-pig sinoatrial node.

作者信息

Russell F D, Kompa A R, Molenaar P, Summers R J

机构信息

Department of Pharmacology, University of Melbourne, Parkville, Victoria, Australia.

出版信息

Naunyn Schmiedebergs Arch Pharmacol. 1994 May;349(5):463-72. doi: 10.1007/BF00169134.

DOI:10.1007/BF00169134
PMID:7915007
Abstract

This study examined the changes of beta-adrenoceptors in the guinea-pig sinoatrial nodal region following 7 day (-)-isoprenaline (400 micrograms/kg/h s.c.) infusion and the relationship between beta-adrenoceptor desensitization and receptor down-regulation. Changes in beta 1- and beta 2-adrenoceptor density were measured using quantitative autoradiography and function in organ bath studies. (-)-Isoprenaline treatment produced a marked decrease in total (from 57.5 to 33.9 fmol/mg protein), beta 1- (from 49.4 to 32.8 fmol/mg protein), and beta 2-adrenoceptor density (from 8.1 to 1.05 fmol/mg protein) in the sinoatrial node. In adjacent right atrium, treatment produced no change in total (39.5 and 36.7 fmol/mg protein) or beta 1-adrenoceptors (35.9 and 36.4 fmol/mg protein) but did decrease beta 2-adrenoceptors (from 3.7 to 0.3 fmol/mg protein). Chronotropic effects were measured in spontaneously beating right atrium. Procaterol, a selective beta 2-adrenoceptor agonist, caused a biphasic chronotropic response in control right atria, the first part of which was abolished in the tissue from treated animals. The maximum increase in right atrial rate to RO363, a beta 1-adrenoceptor selective partial agonist, was reduced from 114 bpm in control to 43 bpm in treated animals. In electrically driven right atrium with the sinoatrial node removed procaterol failed to produce a positive inotropic response via beta 2-adrenoceptors, but the maximum response to RO363 was reduced from 0.75 g in the control tissue to 0.12 g in the treated tissue. This study showed that changes in beta 2-adrenoceptor density following 7 day (-)-isoprenaline infusion are compatible with reduced functional responsiveness in the SA node. The reduction of beta 1-adrenoceptor number in the SA node was also compatible with the reduced chronotropic response in this tissue. However the lack of effect on beta 1-adrenoceptor density in the right atrium was not consistent with the decrease in beta 1-adrenoceptor mediated inotropic response in this tissue. This suggests that beta-adrenoceptor desensitization is not always associated with receptor down-regulation but depends also on the changes in the cell signalling system beyond the level of the receptor which differ according to the cardiac location.

摘要

本研究检测了豚鼠窦房结区域在皮下输注7天(-)-异丙肾上腺素(400微克/千克/小时)后β-肾上腺素能受体的变化,以及β-肾上腺素能受体脱敏与受体下调之间的关系。使用定量放射自显影法测定β1和β2肾上腺素能受体密度的变化,并通过器官浴实验检测其功能。(-)-异丙肾上腺素治疗使窦房结中的总β-肾上腺素能受体密度(从57.5飞摩尔/毫克蛋白质降至33.9飞摩尔/毫克蛋白质)、β1-肾上腺素能受体密度(从49.4飞摩尔/毫克蛋白质降至32.8飞摩尔/毫克蛋白质)和β2-肾上腺素能受体密度(从8.1飞摩尔/毫克蛋白质降至1.05飞摩尔/毫克蛋白质)显著降低。在相邻的右心房中,治疗对总β-肾上腺素能受体密度(39.5和36.7飞摩尔/毫克蛋白质)或β1-肾上腺素能受体密度(35.9和36.4飞摩尔/毫克蛋白质)没有影响,但使β2-肾上腺素能受体密度降低(从3.7飞摩尔/毫克蛋白质降至0.3飞摩尔/毫克蛋白质)。在自发搏动的右心房中测量变时效应。选择性β2-肾上腺素能受体激动剂丙卡特罗在对照右心房中引起双相变时反应,其第一部分在治疗动物的组织中被消除。β1-肾上腺素能受体选择性部分激动剂RO363使右心房率的最大增加幅度从对照时的114次/分钟降至治疗动物时的43次/分钟。在去除窦房结的电驱动右心房中,丙卡特罗未能通过β2-肾上腺素能受体产生正性肌力反应,但对RO363的最大反应从对照组织中的0.75克降至治疗组织中的0.12克。本研究表明,7天(-)-异丙肾上腺素输注后β2-肾上腺素能受体密度的变化与窦房结功能反应性降低一致。窦房结中β1-肾上腺素能受体数量的减少也与该组织中变时反应的降低一致。然而,对右心房中β1-肾上腺素能受体密度缺乏影响与该组织中β1-肾上腺素能受体介导的肌力反应降低不一致。这表明β-肾上腺素能受体脱敏并不总是与受体下调相关,还取决于受体水平之外细胞信号系统的变化,而这种变化因心脏部位而异。

相似文献

1
Regulation of beta-adrenoceptors in the guinea-pig sinoatrial node.豚鼠窦房结中β-肾上腺素能受体的调节
Naunyn Schmiedebergs Arch Pharmacol. 1994 May;349(5):463-72. doi: 10.1007/BF00169134.
2
Function, characterization and autoradiographic localization and quantitation of beta-adrenoceptors in cardiac tissues.心脏组织中β-肾上腺素能受体的功能、特性、放射自显影定位及定量分析
Clin Exp Pharmacol Physiol. 1989 Jun;16(6):529-33. doi: 10.1111/j.1440-1681.1989.tb01600.x.
3
Characterization of beta-1 and beta-2 adrenoceptors in guinea pig atrium: functional and receptor binding studies.豚鼠心房中β-1和β-2肾上腺素能受体的特征:功能和受体结合研究。
J Pharmacol Exp Ther. 1987 Jun;241(3):1041-7.
4
Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.(-)-RO363 对人心脏β-肾上腺素能受体亚型、人克隆β3-肾上腺素能受体及啮齿动物肠道β3-肾上腺素能受体的作用。
Br J Pharmacol. 1997 Jan;120(2):165-76. doi: 10.1038/sj.bjp.0700850.
5
Cardiostimulant and cardiodepressant effects through overexpressed human beta2-adrenoceptors in murine heart: regional differences and functional role of beta1-adrenoceptors.通过在小鼠心脏中过表达人β2肾上腺素能受体产生的心脏刺激和心脏抑制作用:β1肾上腺素能受体的区域差异和功能作用
Naunyn Schmiedebergs Arch Pharmacol. 2003 Apr;367(4):380-90. doi: 10.1007/s00210-002-0681-4. Epub 2003 Mar 4.
6
Abolition of (-)-CGP 12177-evoked cardiostimulation in double beta1/beta2-adrenoceptor knockout mice. Obligatory role of beta1-adrenoceptors for putative beta4-adrenoceptor pharmacology.在双β1/β2肾上腺素能受体基因敲除小鼠中消除(-)-CGP 12177诱发的心脏刺激作用。β1肾上腺素能受体在假定的β4肾上腺素能受体药理学中的必要作用。
Naunyn Schmiedebergs Arch Pharmacol. 2001 Jan;363(1):87-93. doi: 10.1007/s002100000336.
7
Pharmacological analysis of the cardiac actions of xamoterol, a beta adrenoceptor antagonist with partial agonistic activity, in guinea pig heart: evidence for involvement of adenylate cyclase system in its cardiac stimulant actions.对具有部分激动活性的β肾上腺素能受体拮抗剂扎莫特罗在豚鼠心脏中的心脏作用进行药理学分析:腺苷酸环化酶系统参与其心脏兴奋作用的证据。
J Pharmacol Exp Ther. 1987 Sep;242(3):1077-85.
8
Stimulant and blocking effects of optical isomers of pindolol on the sinoatrial node and trachea of guinea pig. Role of beta-adrenoceptor subtypes in the dissociation between blockade and stimulation.吲哚洛尔光学异构体对豚鼠窦房结和气管的兴奋及阻断作用。β-肾上腺素能受体亚型在阻断与兴奋解离中的作用。
Naunyn Schmiedebergs Arch Pharmacol. 1984 Sep;327(2):159-75. doi: 10.1007/BF00500912.
9
Comparative analysis of beta-1 adrenoceptor agonist and antagonist potency and selectivity of cicloprolol, xamoterol and pindolol.环丙洛尔、扎莫特罗和吲哚洛尔对β-1肾上腺素能受体激动剂及拮抗剂效能和选择性的比较分析
J Pharmacol Exp Ther. 1987 Sep;242(3):1025-34.
10
The affinity and efficacy of the selective beta 1-adrenoceptor stimulant RO363 at beta 1- and beta 2-adrenoceptor sites.选择性β1肾上腺素能受体激动剂RO363在β1和β2肾上腺素能受体位点的亲和力和效能。
Br J Pharmacol. 1984 Aug;82(4):897-904. doi: 10.1111/j.1476-5381.1984.tb16488.x.

引用本文的文献

1
Chronic sympathetic activation promotes downregulation of β-adrenoceptor-mediated effects in the guinea pig heart independently of structural remodeling and systolic dysfunction.慢性交感神经激活促进豚鼠心脏β肾上腺素能受体介导作用的下调,而不依赖于结构重塑和收缩功能障碍。
Pflugers Arch. 2011 Oct;462(4):529-43. doi: 10.1007/s00424-011-1005-7. Epub 2011 Aug 3.
2
Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.持续性β-肾上腺素能受体激活所致的心脏肥大:病理生理学方面
Heart Fail Rev. 2007 Mar;12(1):66-86. doi: 10.1007/s10741-007-9007-4. Epub 2007 Mar 27.
3
Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion.

本文引用的文献

1
Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.衰竭的人类心脏中β-肾上腺素能受体激酶和β1-肾上腺素能受体的表达改变。
Circulation. 1993 Feb;87(2):454-63. doi: 10.1161/01.cir.87.2.454.
2
Review important concepts of receptor theory.复习受体理论的重要概念。
J Auton Pharmacol. 1982 Dec;2(4):277-95. doi: 10.1111/j.1474-8673.1982.tb00520.x.
3
Reserpine-induced changes in cardiac adrenergic receptors.利血平引起的心脏肾上腺素能受体变化。
慢性异丙肾上腺素输注后大鼠心脏组织中β-肾上腺素能受体信号通路脱敏的功能分析
Br J Pharmacol. 1999 Jun;127(4):1012-20. doi: 10.1038/sj.bjp.0702618.
4
Chronic (-)-isoprenaline infusion down-regulates beta 1- and beta 2-adrenoceptors but does not transregulate muscarinic cholinoceptors in rat heart.慢性输注(-)-异丙肾上腺素可下调大鼠心脏中的β1和β2肾上腺素能受体,但不会对毒蕈碱胆碱能受体进行转调节。
Naunyn Schmiedebergs Arch Pharmacol. 1996 Jan;353(2):213-25. doi: 10.1007/BF00168760.
Can J Physiol Pharmacol. 1984 Jan;62(1):23-6. doi: 10.1139/y84-003.
4
Evidence for intravesicular beta-adrenergic receptors in membrane fractions from desensitized cells: binding of the hydrophilic ligand CGP-12177 only in the presence of alamethicin.
J Cyclic Nucleotide Protein Phosphor Res. 1983;9(2):119-28.
5
Heart beta-receptors: on the functional role of heterogeneous binding sites.心脏β受体:关于异质结合位点的功能作用
J Recept Res. 1983;3(1-2):61-70. doi: 10.3109/10799898309041923.
6
Modulation of noradrenaline release through activation of presynaptic beta-adrenoreceptors.通过激活突触前β-肾上腺素能受体来调节去甲肾上腺素释放。
J Auton Pharmacol. 1983 Mar;3(1):47-60. doi: 10.1111/j.1474-8673.1983.tb00496.x.
7
Desensitization of the beta-adrenergic receptor of frog erythrocytes. Recovery and characterization of the down-regulated receptors in sequestered vesicles.青蛙红细胞β-肾上腺素能受体的脱敏。隔离囊泡中下调受体的恢复与特性研究。
J Biol Chem. 1983 Mar 10;258(5):3032-8.
8
beta-Adrenoceptor ligand binding and supersensitivity to isoprenaline of ventricular muscle after chronic reserpine pretreatment.慢性利血平预处理后心室肌β-肾上腺素能受体配体结合及对异丙肾上腺素的超敏感性
Naunyn Schmiedebergs Arch Pharmacol. 1982 Sep;320(3):240-5. doi: 10.1007/BF00510135.
9
Catecholamine-specific desensitization of adenylate cyclase. Evidence for a multistep process.腺苷酸环化酶的儿茶酚胺特异性脱敏。多步骤过程的证据。
J Biol Chem. 1980 Aug 10;255(15):7410-9.
10
The pharmacology of a beta 2-selective adrenoceptor antagonist (ICI 118,551).一种β2 选择性肾上腺素能受体拮抗剂(ICI 118,551)的药理学
J Cardiovasc Pharmacol. 1983 May-Jun;5(3):430-7. doi: 10.1097/00005344-198305000-00013.